Literature DB >> 24105654

The role of epidemiology in the era of molecular epidemiology and genomics: Summary of the 2013 AJE-sponsored Society of Epidemiologic Research Symposium.

Lewis H Kuller, Michael B Bracken, Shuji Ogino, Ross L Prentice, Russell P Tracy.   

Abstract

On June 20, 2013, the American Journal of Epidemiology sponsored a symposium at the Society for Epidemiologic Research's 46th Annual Meeting in Boston, Massachusetts, entitled, "What Is the Role of Epidemiology in the Era of Molecular Biology and Genomics?" The future of epidemiology depends on innovation in generating interesting and important testable hypotheses that are relevant to population health. These new strategies will depend on new technology, both in measurement of agents and environment and in the fields of pathophysiology and outcomes, such as cellular epidemiology and molecular pathology. The populations to be studied, sample sizes, and study designs should be selected based on the hypotheses to be tested and include case-control, cohort, and clinical trials. Developing large mega cohorts without attention to specific hypotheses is inefficient, will fail to address many associations with high-quality data, and may well produce spurious results.

Keywords:  immunology; pathology; study design

Mesh:

Year:  2013        PMID: 24105654      PMCID: PMC3988450          DOI: 10.1093/aje/kwt239

Source DB:  PubMed          Journal:  Am J Epidemiol        ISSN: 0002-9262            Impact factor:   4.897


  19 in total

Review 1.  Integration of microbiology, molecular pathology, and epidemiology: a new paradigm to explore the pathogenesis of microbiome-driven neoplasms.

Authors:  Tsuyoshi Hamada; Jonathan A Nowak; Danny A Milner; Mingyang Song; Shuji Ogino
Journal:  J Pathol       Date:  2019-02-20       Impact factor: 7.996

Review 2.  Molecular pathological epidemiology: new developing frontiers of big data science to study etiologies and pathogenesis.

Authors:  Tsuyoshi Hamada; NaNa Keum; Reiko Nishihara; Shuji Ogino
Journal:  J Gastroenterol       Date:  2016-10-13       Impact factor: 7.527

3.  Review Article: The Role of Molecular Pathological Epidemiology in the Study of Neoplastic and Non-neoplastic Diseases in the Era of Precision Medicine.

Authors:  Shuji Ogino; Reiko Nishihara; Tyler J VanderWeele; Molin Wang; Akihiro Nishi; Paul Lochhead; Zhi Rong Qian; Xuehong Zhang; Kana Wu; Hongmei Nan; Kazuki Yoshida; Danny A Milner; Andrew T Chan; Alison E Field; Carlos A Camargo; Michelle A Williams; Edward L Giovannucci
Journal:  Epidemiology       Date:  2016-07       Impact factor: 4.822

4.  Statistics: Biomedicine must look beyond P values.

Authors:  Anne-Louise Ponsonby; Terence Dwyer
Journal:  Nature       Date:  2014-03-13       Impact factor: 49.962

Review 5.  The next generation of large-scale epidemiologic research: implications for training cancer epidemiologists.

Authors:  Margaret R Spitz; Tram Kim Lam; Sheri D Schully; Muin J Khoury
Journal:  Am J Epidemiol       Date:  2014-09-18       Impact factor: 4.897

6.  The limitations of opportunistic epidemiology, pseudopod epidemiology.

Authors:  Lewis H Kuller
Journal:  Eur J Epidemiol       Date:  2016-09-03       Impact factor: 8.082

Review 7.  Integrative analysis of exogenous, endogenous, tumour and immune factors for precision medicine.

Authors:  Shuji Ogino; Jonathan A Nowak; Tsuyoshi Hamada; Amanda I Phipps; Ulrike Peters; Danny A Milner; Edward L Giovannucci; Reiko Nishihara; Marios Giannakis; Wendy S Garrett; Mingyang Song
Journal:  Gut       Date:  2018-02-06       Impact factor: 23.059

Review 8.  Evolution of the "drivers" of translational cancer epidemiology: analysis of funded grants and the literature.

Authors:  Tram Kim Lam; Christine Q Chang; Scott D Rogers; Muin J Khoury; Sheri D Schully
Journal:  Am J Epidemiol       Date:  2015-03-11       Impact factor: 4.897

Review 9.  The hallmarks of premalignant conditions: a molecular basis for cancer prevention.

Authors:  Bríd M Ryan; Jessica M Faupel-Badger
Journal:  Semin Oncol       Date:  2015-09-08       Impact factor: 4.929

Review 10.  Design and Analysis for Studying microRNAs in Human Disease: A Primer on -Omic Technologies.

Authors:  Viswam S Nair; Colin C Pritchard; Muneesh Tewari; John P A Ioannidis
Journal:  Am J Epidemiol       Date:  2014-06-24       Impact factor: 4.897

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.